Genotyping FcɣRs Genes of HIV-1 Patients Progressor: Correlation With the Changing Profile of the Infection

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03130296

Enrollment

230

Registered

2017-04-26

Start date

2017-02-16

Completion date

2020-02-16

Last updated

2017-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infection

Keywords

HIV infection, Fc receptor polymorphism (FcR)

Brief summary

This non-interventional study aims to determine whether there is a correlation between the Fc receptor polymorphism (FcR) and the course of the disease following HIV infection.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient aged 18 or older, * Patient affiliated to a social security scheme, * Informed consent dated and signed by the investigating physician the patient, * Patients infected with HIV-1 having progressed in clinical (stage C) or biologically (CD4 nadir \<350 / mm3 and viral load\> 10,000 copies / ml)

Exclusion criteria

* Impossibility of giving the subject informed information (subject in an emergency situation, difficulty in understanding the subject, ...) * Subject under safeguard of justice, * Subject under tutelage or under curatorship,

Design outcomes

Primary

Measure	Time frame
Correlation research between Fc receptor polymorphism (FcR) and the course of disease following HIV infection.	After infection, up to 12 months

Countries

France

Contacts

Primary ContactDavid REY, MD

David.Rey@chru-strasbourg.fr33 3 69 55 05 01

Backup ContactChristiane MOOG, PhD

c.moog@unistra.fr33 3 68 85 37 42

Outcome results